Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.036 | 0.8 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |